CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the 13th Annual BIO CEO & Investor Conference being held at the Waldorf=Astoria Hotel in New York City, New York. Harvey J. Berger, M.D., chairman and chief executive officer at ARIAD, will provide an overview of the Company’s robust oncology pipeline and progress on its three lead compounds on Monday, February 14, 2011 at 11:00 a.m. (ET).
